Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

RCEL

AVITA Medical Inc

Feb 13 • 04:00PM ET

4.16

+0.44 11.83 %

Healthcare • Medical Devices • USA • NASD

Feb 13, 3:12 AMAVITA posts a Q4 FY2025 miss (non-GAAP EPS -$0.38; revenue $17.4M) but says FY2025 was in-line with revenue up 11% to $71.6M, stabilizes reimbursement as 6 of 7 MACs publish RECELL payment rates, refinances debt under a Perceptive Advisors credit facility, and guides 2026 revenue to $80–85M (mid-teens growth).

Peers: MDT ABT BSX ISRG SYK BDX EW PEN ZBH STE

| Held by: VTI VXF IWM IWO VTWO ITOT IWC GSSC VTWG IWV

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.75	Insider Own	1.09%	Shs Outstand	30.57M	Perf Week	6.67%
Market Cap	103.33M	Forward P/E	-	EPS next Y	-0.45	Insider Trans	8.84%	Shs Float	24.57M	Perf Month	18.18%
Enterprise Value	131.19M	PEG	-	EPS next Q	-0.27	Inst Own	20.94%	Short Float	15.33%	Perf Quarter	10.05%
Income	-48.59M	P/S	1.44	EPS this Y	51.40%	Inst Trans	-6.52%	Short Ratio	17.63	Perf Half Y	-28.28%
Sales	71.61M	P/B	-	EPS next Y	47.09%	ROA	-71.40%	Short Interest	3.77M	Perf YTD	20.58%
Book/sh	-0.54	P/C	5.68	EPS next 5Y	-	ROE	-1746.27%	52W High	11.25 -63.02%	Perf Year	-52.62%
Cash/sh	0.73	P/FCF	-	EPS past 3/5Y	-17.81% 3.38%	ROIC	-	52W Low	3.22 29.19%	Perf 3Y	-55.56%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	27.66% 38.09%	Gross Margin	82.13%	Volatility	10.79% 7.80%	Perf 5Y	-83.60%
Dividend TTM	-	EV/Sales	1.83	EPS Y/Y TTM	26.80%	Oper. Margin	-59.40%	ATR (14)	0.30	Perf 10Y	-48.00%
Dividend Ex-Date	-	Quick Ratio	0.46	Sales Y/Y TTM	11.45%	Profit Margin	-67.85%	RSI (14)	55.68	Recom	1.75
Dividend Gr. 3/5Y	- -	Current Ratio	0.57	EPS Q/Q	13.70%	SMA20	0.65%	Beta	1.82	Target Price	7.39
Payout	-	Debt/Eq	-	Sales Q/Q	-4.30%	SMA50	12.00%	Rel Volume	1.70	Prev Close	3.72
Employees	226	LT Debt/Eq	-	Earnings	Feb 12 AMC	SMA200	-15.06%	Avg Volume	213.56K	Price	4.16
IPO	Mar 29, 2012	Option/Short	Yes / Yes	EPS/Sales Surpr.	-4.28% -2.27%	Trades		Volume	362,380	Change	11.83%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-20-25	Upgrade	BTIG Research	Sell → Neutral
Aug-08-25	Downgrade	BTIG Research	Neutral → Sell	$3
Dec-24-24	Initiated	D. Boral Capital	Buy	$25
Apr-11-24	Downgrade	BTIG Research	Buy → Neutral
Jun-27-23	Initiated	Cantor Fitzgerald	Overweight	$23
Mar-02-21	Initiated	Piper Sandler	Overweight	$27
Aug-27-20	Initiated	BofA Securities	Buy	$42
Apr-21-20	Initiated	Oppenheimer	Outperform	$9
Mar-03-20	Initiated	BTIG Research	Buy	$10

Feb-13-26 09:15AM	AVITA Medical to Host Investor Webinar Briefing (GlobeNewswire) +11.83%
12:03AM	AVITA Medical Inc (AVHHL) Q4 2025 Earnings Call Highlights: Navigating Growth and Challenges (GuruFocus.com)
Feb-12-26 08:14PM	Avita Medical Q4 Earnings Call Highlights (MarketBeat)
08:06PM	AVITA Medical, Inc. Q4 2025 Earnings Call Summary (Moby)
04:01PM	AVITA Medical Reports Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire)
02:13PM	Loading…
Feb-09-26 02:13PM	Lake Street Raises Price Target on AVITA Medical, Inc. (RCEL) to $3.50, Maintains Hold Rating (Insider Monkey)
Jan-25-26 05:30PM	Data at 2026 Boswick Burn & Wound Symposium highlight first integrated use of AVITA Medical technologies (GlobeNewswire)
Jan-13-26 08:25AM	AVITA Medical: Pre-J.P. Morgan Update Highlights 2025 Revenue Growth, New Debt Facility, and 2026 Growth Outlook (GlobeNewswire)
Jan-05-26 04:05PM	AVITA Medical Announces Changes to its Board of Directors (GlobeNewswire)
Dec-18-25 04:15PM	AVITA Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Nov-24-25 04:15PM	AVITA Medical to Present at the Piper Sandler 37?? Annual Healthcare Conference (GlobeNewswire)
Nov-20-25 09:21AM	Here Are Thursdays Top Wall Street Analyst Research Calls: AON, Apollo Global, Bullish, Jack Henry, Marsh & McClennan, Nasdaq, NVIDIA, and More (24/7 Wall St.)
Nov-09-25 05:00PM	AVITA Medical to Host Investor Webinar Briefing (GlobeNewswire)
Nov-06-25 04:05PM	AVITA Medical Reports Third Quarter 2025 Financial Results (GlobeNewswire) +10.88%
Nov-05-25 08:01AM	What To Expect From AVITA Medical Inc (RCEL) Q3 2025 Earnings (GuruFocus.com)
08:30AM	Loading…
Nov-03-25 08:30AM	Data Presented at the 2025 Southern Region Burn Conference Reinforce RECELL System as a Standard of Care in Acute Wound Treatment (GlobeNewswire)
Oct-31-25 04:34AM	New Strong Sell Stocks for Oct. 31st (Zacks) +5.45%
Oct-29-25 04:15PM	AVITA Medical to Announce Third Quarter 2025 Financial Results (GlobeNewswire)
Oct-28-25 04:30PM	AVITA Medical Welcomes Support for RECELL in Burns in Australia (GlobeNewswire)
Oct-16-25 06:15PM	AVITA Medical Announces CEO Transition (GlobeNewswire) -25.84%
Oct-01-25 08:30AM	CMS New Technology Add-On Payment Expands Access to RECELL for Patients with Non-Burn Acute Wounds (GlobeNewswire)
Sep-14-25 07:00PM	AVITA Medical Receives CE Mark for RECELL GO, Enabling Commercialization Across Europe (GlobeNewswire)
Sep-04-25 07:45AM	Real-World Data Shows Significant Reduction in Hospital Stay Using AVITA Medical's RECELL System (GlobeNewswire)
Aug-21-25 04:05PM	AVITA Medical Announces September Investor Conference Participation (GlobeNewswire)
Aug-12-25 08:30AM	AVITA Medical Successfully Completes Australian Equity Raise (GlobeNewswire) +14.76%
Aug-10-25 07:00PM	AVITA Medical to Host Investor Webinar Briefing (GlobeNewswire)
Aug-07-25 04:05PM	AVITA Medical Reports Second Quarter 2025 Financial Results, Updates Full-Year Guidance, and Highlights Continued Clinical Innovation (GlobeNewswire) -21.00%
Aug-06-25 04:05PM	AVITA Medical Announces Appointment of Michael Tarnoff, MD, FACS, to its Board of Directors and Transition of Board Chair Role to Cary Vance (GlobeNewswire)
Jul-28-25 04:05PM	AVITA Medical to Announce Second Quarter 2025 Financial Results (GlobeNewswire)
Jun-09-25 09:00AM	AVITA Medical Highlights Largest Real-World Analysis Demonstrating Reduced Hospital Stay with RECELL (GlobeNewswire)
04:04PM	Loading…
Jun-05-25 04:04PM	AVITA Medical Announces First Clinical Publication Demonstrating Accelerated Autograft Readiness with Cohealyx (GlobeNewswire) +6.26%
Jun-03-25 08:00PM	AVITA Medical's RECELL Platform Recognized for Surgical Innovation in 2025 MedTech Breakthrough Awards (GlobeNewswire)
May-13-25 09:00AM	AVITA Medical's Acute Wound Care Showcase 2025 Streams Live Today (GlobeNewswire)
May-08-25 04:03PM	AVITA Medical Reports First Quarter 2025 Financial Results (GlobeNewswire) -25.29%
Apr-24-25 09:00AM	AVITA Medical to Host Acute Wound Care Showcase on May 13, 2025 (GlobeNewswire)
Apr-17-25 04:05PM	AVITA Medical to Announce First Quarter 2025 Financial Results (GlobeNewswire)
Apr-09-25 04:05PM	AVITA Medical to Present Breakthrough Clinical Data in Burn and Wound Care at ABA 2025 (GlobeNewswire) +13.56%
Apr-03-25 04:03PM	AVITA Medical Launches Cohealyx, Supporting Healing and Unlocking New Market Opportunity (GlobeNewswire)
Mar-17-25 04:05PM	AVITA Medical Announces Exclusive Manufacturing and Distribution Agreements with Stedical Scientific (GlobeNewswire) +5.61%
Mar-13-25 09:55AM	Does Avita Medical (RCEL) Have the Potential to Rally 73.72% as Wall Street Analysts Expect? (Zacks) -7.46%
Feb-26-25 05:30PM	AVITA Medical to Present at TD Cowen's 45?? Annual Health Care Conference (GlobeNewswire) -7.48%
Feb-20-25 10:46AM	AVITA Medical, Inc. (RCEL): A Bull Case Theory (Insider Monkey)
09:55AM	Wall Street Analysts Predict a 52.64% Upside in Avita Medical (RCEL): Here's What You Should Know (Zacks)
Feb-14-25 09:15AM	AVITA Medical to Host Investor Webinar Briefing (GlobeNewswire) +20.39%
Feb-13-25 04:01PM	AVITA Medical Reports Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Jan-09-25 02:04PM	AVITA Medical, Inc. (RCEL): A Bull Case Theory (Insider Monkey)
Jan-07-25 04:35PM	AVITA Medical Updates Expected Fourth Quarter and Full Year 2024 Revenue, Provides 2025 Financial Guidance (GlobeNewswire) -36.42%
Dec-25-24 07:45AM	Cantor Fitzgerald bullish on Avita Medical after FDA approval for RECELL GO Mini (TipRanks)
07:20AM	Avita Medical initiated with a Buy at D. Boral Capital (TipRanks)
Dec-24-24 07:35AM	FDA approves mini version of RECELL GO for smaller wounds (Medical Device Network) +9.87%
Dec-23-24 04:02PM	AVITA Medical Announces FDA Approval of RECELL GO mini, Optimizing Treatment for Smaller Wounds (GlobeNewswire)
Dec-19-24 05:05PM	AVITA Medical Announces FDA 510(k) Clearance for Cohealyx, Expanding its Addressable Market (GlobeNewswire)
Dec-18-24 04:08PM	AVITA Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire) -7.67%
Dec-10-24 10:37PM	Why Is AVITA Medical Inc. (RCEL) Among the Best Cosmetic Surgery and Aesthetics Stocks to Invest In Now? (Insider Monkey)
Nov-30-24 07:18PM	AVITA Medical, Inc. (RCEL): A Bull Case Theory (Insider Monkey)
Nov-25-24 04:02PM	AVITA Medical to Present at the Piper Sandler 36 Annual Healthcare Conference (GlobeNewswire)
Nov-12-24 04:03PM	AVITA Medical Announces Exclusive Distribution Agreement to Expand to Australia and New Zealand (GlobeNewswire)
Nov-08-24 09:00AM	AVITA Medical to Host Investor Webinar Briefing (GlobeNewswire)
Nov-07-24 04:03PM	AVITA Medical Reports Third Quarter Financial Results (GlobeNewswire)
Oct-10-24 05:15PM	AVITA Medical to Announce Third Quarter 2024 Financial Results (GlobeNewswire)
Sep-12-24 04:05PM	AVITA Medical to Present at 2024 Cantor Global Healthcare Conference (GlobeNewswire) +5.77%
Sep-10-24 04:03PM	AVITA Medical to Participate in Lake Street's 8th Annual Best Ideas Growth (BIG8) Conference (GlobeNewswire)
Aug-30-24 10:33AM	AVITA Medical Inc (NASDAQ:RCEL) A Bull Case Theory (Insider Monkey)
Aug-09-24 06:37AM	Is AVITA Medical, Inc. (RCEL) Among the Best Cosmetic Surgery and Aesthetics Stocks to Buy Now? (Insider Monkey) +20.68%
Aug-08-24 07:00PM	AVITA Medical to Host Investor Webinar Briefing (GlobeNewswire)
04:04PM	AVITA Medical Reports Second Quarter Financial Results (GlobeNewswire)
Aug-01-24 04:05PM	AVITA Medical Names Robin VanDenburgh as SVP of U.S. Commercial Sales (GlobeNewswire) -10.97% -5.44%
05:32AM	AVITA signs dermal matrix distribution agreement with Regenity (Medical Device Network)
Jul-31-24 04:05PM	AVITA Medical Expands Portfolio with Unique Dermal Matrix to Advance Wound Care (GlobeNewswire)
Jul-11-24 04:10PM	AVITA Medical to Announce Second Quarter 2024 Financial Results (GlobeNewswire) +5.78% +6.48%
Jul-01-24 04:05PM	AVITA Medical Appoints Nicole Kelsey as Chief Legal and Compliance Officer, and Corporate Secretary (GlobeNewswire)
Jun-05-24 04:25PM	AVITA Medical Achieves Milestone with First Case Using RECELL GO (GlobeNewswire) +7.58%
May-31-24 06:55AM	Avita obtains FDA approval for cell harvesting device Recell GO System (Medical Device Network)
May-30-24 09:15AM	AVITA Medical Announces FDA Approval of RECELL GO (GlobeNewswire) +5.56%
May-16-24 06:30PM	AVITA Medical to Host Investor Webinar Briefing (GlobeNewswire)
May-14-24 08:57AM	Cantor Fitzgerald Trims Price Target on Avita Medical to $21 From $22, Maintains Overweight Rating (MT Newswires)
03:04AM	AVITA Medical Inc (AVHHL) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges ... (GuruFocus.com)
May-13-24 09:55PM	RCEL Stock Earnings: AVITA Medical Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace)
04:01PM	AVITA Medical Reports First Quarter Financial Results (GlobeNewswire)
May-12-24 09:16AM	Spectral AI, Inc. (NASDAQ:MDAI) Q1 2024 Earnings Call Transcript (Insider Monkey)
Apr-15-24 05:05PM	AVITA Medical to Announce First Quarter 2024 Financial Results (GlobeNewswire)
Apr-10-24 05:11PM	AVITA Medical Updates Expected First Quarter 2024 Revenue (GlobeNewswire) -28.32%
Feb-29-24 04:02PM	AVITA Medical Submits Response to FDA, Resuming Review Clock for RECELL GO PMA Supplement (GlobeNewswire) +7.47%
09:00AM	AVITA Medical to Present at TD Cowen 44th Annual Health Care Conference (GlobeNewswire)
Feb-23-24 10:45AM	AVITA Medical, Inc. (NASDAQ:RCEL) Q4 2023 Earnings Call Transcript (Insider Monkey)
09:01AM	AVITA Medical to Host Investor Webinar Briefing (GlobeNewswire)
Feb-22-24 04:45PM	AVITA Medical Inc (RCEL) Reports Robust Revenue Growth in Q4 and Full-Year 2023 (GuruFocus.com)
04:01PM	AVITA Medical Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance (GlobeNewswire)
Feb-01-24 04:10PM	AVITA Medical to Announce Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Jan-10-24 04:01PM	AVITA Medical Announces Exclusive Distribution Agreement with Stedical Scientific (GlobeNewswire)
09:01AM	AVITA Medical Announces Preliminary 2023 Financial Highlights, Provides 2024 Financial Guidance and Business Update (GlobeNewswire)
Jan-04-24 09:00AM	AVITA Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-04-23 09:00AM	AVITA Medical to Host Investor Webinar Briefing (GlobeNewswire)
Nov-21-23 04:15PM	AVITA Medical to Present at the Piper Sandler 35th Annual Healthcare Conference (GlobeNewswire) -18.90%
Nov-20-23 04:15PM	AVITA Medical Updates Full Year 2023 Guidance (GlobeNewswire)
Nov-10-23 03:04PM	AVITA Medical, Inc. (NASDAQ:RCEL) Q3 2023 Earnings Call Transcript (Insider Monkey) +14.27%
Nov-09-23 04:01PM	AVITA Medical Reports Third Quarter Financial Results with 51% Revenue Growth over the Same Period the Prior Year (GlobeNewswire)
09:00AM	AVITA Medical Announces Distribution Partnership with PolyMedics Innovations to Expand to Europe (GlobeNewswire)
Oct-19-23 04:05PM	AVITA Medical to Announce Third Quarter 2023 Financial Results (GlobeNewswire)
Oct-18-23 09:00AM	AVITA Medical Announces Preliminary Third Quarter 2023 Financial Highlights and Secures up to $90 million of Non-Dilutive Debt Financing with OrbiMed to Support Growth Initiatives (GlobeNewswire) -5.65%

AVITA Medical, Inc., through its subsidiaries, engages in the development and commercialization of a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs. Its product, RECELL system, is a device that enables healthcare professionals to produce a suspension of spray-on skin cells using a small sample of the patient's own skin for the treatment of acute thermal burns. The company was founded in December 1992 and is headquartered in Valencia, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
McNamara Robert	Director	Aug 28 '25	Buy	4.50	10,000	45,000	86,771	Aug 29 04:30 PM
O'Toole David D	CFO	Aug 26 '25	Buy	4.52	2,000	9,040	31,657	Aug 26 04:30 PM
McNamara Robert	Director	Aug 19 '25	Buy	5.00	10,000	50,000	76,771	Aug 20 06:11 PM
O'Toole David D	CFO	Aug 12 '25	Buy	4.81	2,000	9,620	29,657	Aug 12 04:30 PM
McNamara Robert	Director	Mar 06 '25	Buy	8.30	11,000	91,300	56,749	Mar 10 04:30 PM
McNamara Robert	Director	Feb 20 '25	Buy	10.09	10,000	100,900	45,749	Feb 20 04:30 PM
O'Toole David D	CFO	Feb 20 '25	Buy	9.90	1,000	9,900	25,734	Feb 20 04:30 PM
O'Toole David D	CFO	Feb 19 '25	Buy	10.25	1,000	10,250	24,734	Feb 19 04:30 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

RCEL

AVITA Medical Inc

Upgrade your FINVIZ experience